Patents by Inventor Susan Weinbach

Susan Weinbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110256217
    Abstract: Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.
    Type: Application
    Filed: June 16, 2009
    Publication date: October 20, 2011
    Applicant: Isis Pharmaceuticals, Inc.
    Inventors: Susan Weinbach, Lloyd G. Tillman, Richard S. Geary, Gregory E. Hardee
  • Patent number: 8039444
    Abstract: A pharmaceutical composition comprising an antisense oligonucleotide and a permeation enhancer that comprises a multi-carbon backbone having a functional group and also one or more side chains which have one or more carbon atoms and, optionally, one or more functional groups.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: October 18, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Araz A. Raoof, Mangaraju Gudipati, David C. Bibby, Susan Weinbach
  • Patent number: 7576067
    Abstract: Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: August 18, 2009
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Susan Weinbach, Lloyd G. Tillman, Richard S. Geary, Gregory E. Hardee
  • Publication number: 20050196443
    Abstract: Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.
    Type: Application
    Filed: December 1, 2004
    Publication date: September 8, 2005
    Applicant: ISIS Pharmaceuticals, Inc.
    Inventors: Susan Weinbach, Lloyd Tillman, Richard Geary, Gregory Hardee
  • Publication number: 20030176379
    Abstract: A pharmaceutical composition comprising an antisense oligonucleotide and a permeation enhancer that comprises a multi-carbon backbone having a functional group and also one or more side chains which have one or more carbon atoms and, optionally, one or more functional groups.
    Type: Application
    Filed: May 13, 2002
    Publication date: September 18, 2003
    Inventors: Araz A. Raoof, Mangaraju Gudipati, David C. Bibby, Susan Weinbach Reingold
  • Publication number: 20030124196
    Abstract: Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.
    Type: Application
    Filed: August 22, 2001
    Publication date: July 3, 2003
    Inventors: Susan Weinbach, Lloyd G. Tillman, Richard S. Geary, Gregory E. Hardee